Ventricular arrhythmias in congestive heart failure

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Congestive heart failure (CHF) is associated with high mortality, often due to sudden cardiac death from ventricular arrhythmias.
• Ventricular arrhythmias, including nonsustained ventricular tachycardia, are prevalent in CHF patients and predict mortality.
• Structural heart changes in CHF may predispose ventricles to life-threatening arrhythmias.

Purpose of the Study:

• To discuss the multifactorial pathogenesis of ventricular arrhythmias in CHF.
• To review the role of various drugs in the development and treatment of these arrhythmias.
• To evaluate the controversial efficacy of antiarrhythmic therapy for asymptomatic ventricular tachycardia.

Main Methods:

• Literature review on the pathogenesis and treatment of ventricular arrhythmias in CHF.
• Discussion of contributing factors like electrolyte imbalances, ischemia, and drug effects.
• Analysis of the impact of medications such as beta-blockers and ACE inhibitors.

Main Results:

• Ventricular arrhythmias are common in CHF and linked to increased mortality.
• Several factors can exacerbate arrhythmias, while certain medications show benefit.
• The benefit of treating asymptomatic nonsustained ventricular tachycardia is debated.

Conclusions:

• Pharmacotherapy guided by electrophysiologic testing is recommended for sustained ventricular tachycardia.
• Automatic implantable cardioverter-defibrillators may be necessary for patients resuscitated from ventricular fibrillation.
• Further research is needed to clarify optimal antiarrhythmic strategies for CHF patients.